Gao, Lucy
Medford, Arielle
Spring, Laura
Bar, Yael
Hu, Bonnie
Jimenez, Rachel
Isakoff, Steven J.
Bardia, Aditya
Peppercorn, Jeffrey http://orcid.org/0000-0001-7138-6404
Article History
Received: 14 August 2023
Accepted: 8 January 2024
First Online: 15 February 2024
Declarations
:
: The following authors declare financial relationships, none directly related to the work submitted: Jeffrey Peppercorn reports a family member employed by GSK. Arielle Medford has consulted for Guardant Health, Illumina, and Natera. Laura Spring has received research funding from Merck, Phillips, and Eli Lilly, and has consulted for Novartis and Puma. Steven J Isakoff has received research funding from Abbvie, Astra Zeneca, Genentech, Merck, and OncoPep, and has consulted for Seattle Genetics, Novartis, Paxman, and Puma, and reports a family member employed by Merus NV. Aditya Bardia has consulted for Pfizer, Novartis, Genentech, Merck, Radius Health, Immunomedics/Gilead, Sanofi, Daiichi Pharma/Astra Zeneca, Phillips, Eli Lilly, Foundation Medicine and he reports research funding from Genentech, Novartis, Pfizer, Merck, Sanofi, Radius Health, Immunomedics/Gilead, Daiichi Pharma/Astra Zeneca, and Eli Lilly.